AngioDynamics, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
AngioDynamics, Inc. (ANGO) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of -$422.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-07-14
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2016-05-31 was $197.00K, a 131.76% increase year-over-year.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2016-02-29 was $302.00K, a 41.81% decline year-over-year.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2015-05-31 was $85.00K, a 63.98% decline year-over-year.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2015-02-28 was $519.00K.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2026 was -$422.00K, a 184.91% decline from fiscal 2025.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $497.00K, a 45.20% decline from fiscal 2024.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $907.00K, a 8.48% decline from fiscal 2023.
- AngioDynamics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $991.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | -$422.00K 10-K · filed 2026-07-14 | ||||
| 2025-05-31 | $497.00K 10-K · filed 2026-07-14 | ||||
| 2024-05-31 | $907.00K 10-K · filed 2026-07-14 | ||||
| 2023-05-31 | $991.00K 10-K · filed 2025-07-18 | ||||
| 2022-05-31 | -$395.00K 10-K · filed 2024-07-25 | ||||
| 2021-05-31 | $1.30M 10-K · filed 2023-08-03 | ||||
| 2020-05-31 | $1.15M 10-K · filed 2022-07-22 | ||||
| 2019-05-31 | $936.00K 10-K · filed 2021-07-27 | ||||
| 2018-05-31 | $951.00K 10-K · filed 2020-08-10 | ||||
| 2017-05-31 | $403.00K 10-K · filed 2019-07-25 | ||||
| 2016-05-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23 | $499.00K derived: sum of 2 quarters · filed 2018-07-23 | $499.00K 10-K · filed 2018-07-23 | ||
| 2016-02-29 | $302.00K 10-Q · filed 2016-04-11 | $302.00K 10-Q · filed 2016-04-11 | |||
| 2015-05-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04 | $604.00K derived: sum of 2 quarters · filed 2017-08-04 | $604.00K 10-K · filed 2017-08-04 | ||
| 2015-02-28 | $519.00K 10-Q · filed 2016-04-11 | $519.00K 10-Q · filed 2016-04-11 | |||
| 2014-05-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $236.00K derived: sum of 2 quarters · filed 2016-08-01 | $236.00K 10-K · filed 2016-08-01 | -$236.00K 10-K · filed 2014-08-14 | |
| 2014-02-28 | $0.00 10-Q · filed 2015-04-09 | $0.00 10-Q · filed 2015-04-09 | |||
| 2013-05-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10 | $142.00K derived: sum of 2 quarters · filed 2015-08-10 | $142.00K 10-K · filed 2015-08-10 | -$142.00K 10-K · filed 2013-08-14 | |
| 2013-02-28 | $129.00K 10-Q · filed 2013-04-09 | $129.00K 10-Q · filed 2014-04-09 | |||
| 2012-05-31 | -$115.00K 10-K · filed 2015-01-12 | ||||
| 2011-05-31 | -$549.00K 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |